Variant report
Variant | nsv1003336 |
---|---|
Chromosome Location | chr3:102945342-102962981 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr3:102953005-102953138 | Kidney_OC | kidney: | n/a | n/a |
2 | CTCF | chr3:102946747-102946783 | LNCaP | prostate: | n/a | n/a |
3 | CTCF | chr3:102954489-102954521 | GM10248 | blood: | n/a | n/a |
4 | CTCF | chr3:102952983-102953139 | GM10248 | blood: | n/a | n/a |
5 | EP300 | chr3:102946317-102947898 | SK-N-SH | brain: | n/a | chr3:102947492-102947501 chr3:102946726-102946733 chr3:102947177-102947191 |
6 | GATA3 | chr3:102960635-102960668 | SH-SY5Y | brain: | n/a | n/a |
7 | GATA3 | chr3:102958217-102958440 | SH-SY5Y | brain: | n/a | n/a |
8 | MAFK | chr3:102951163-102951451 | HepG2 | liver: | n/a | chr3:102951299-102951310 chr3:102951299-102951315 chr3:102951299-102951310 chr3:102951300-102951311 |
9 | MAFK | chr3:102951215-102951424 | IMR90 | lung: | n/a | chr3:102951299-102951310 chr3:102951299-102951315 chr3:102951299-102951310 chr3:102951300-102951311 |
10 | MAFK | chr3:102961419-102961522 | HepG2 | liver: | n/a | n/a |
11 | NFYB | chr3:102946000-102946200 | GM12878 | blood: | n/a | n/a |
12 | NRF1 | chr3:102947664-102947782 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | POLR2A | chr3:102959001-102959048 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr3:102948937-102948980 | GM12878 | blood: | n/a | n/a |
15 | POLR2A | chr3:102959748-102959812 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZPLD1-7 | chr3:102959831-102960074 | NONHSAT090940 |
No data |
No data |
Variant related genes | Relation type |
---|---|
NDUFA4P2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190019832 | chr3:102958224-102958225 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs569000167 | chr3:102958248-102958249 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs115272583 | chr3:102958250-102958251 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs150407324 | chr3:102958299-102958300 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs566885013 | chr3:102958334-102958335 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs138196617 | chr3:102958344-102958345 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs181489213 | chr3:102958371-102958372 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs149596673 | chr3:102958388-102958389 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs538497161 | chr3:102958399-102958400 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs556918367 | chr3:102958421-102958422 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs527496118 | chr3:102959006-102959007 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs375610476 | chr3:102959009-102959010 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs144331444 | chr3:102959011-102959012 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs79548476 | chr3:102959761-102959762 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs77750117 | chr3:102959847-102959848 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs10511208 | chr3:102959848-102959849 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs572458114 | chr3:102959876-102959877 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs543074488 | chr3:102959883-102959884 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs10737948 | chr3:102959934-102959935 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs111428832 | chr3:102959935-102959936 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs550256386 | chr3:102959983-102959984 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs565287870 | chr3:102960026-102960027 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs182991879 | chr3:102960038-102960039 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs10511209 | chr3:102960039-102960040 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs530252948 | chr3:102961254-102961255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572429563 | chr3:102961259-102961260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542084100 | chr3:102961263-102961264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563672887 | chr3:102961295-102961296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189022847 | chr3:102961318-102961319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552199013 | chr3:102961338-102961339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570447022 | chr3:102961382-102961383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536675650 | chr3:102961394-102961395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528149228 | chr3:102961451-102961452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539553563 | chr3:102961455-102961456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554663197 | chr3:102961485-102961486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs368342512 | chr3:102961493-102961494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs116164157 | chr3:102961501-102961502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140430118 | chr3:102961552-102961553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1389048 | chr3:102961581-102961582 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs569160547 | chr3:102961602-102961603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143645274 | chr3:102961624-102961625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs181422471 | chr3:102961632-102961633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577176196 | chr3:102961633-102961634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541099816 | chr3:102961649-102961650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553067971 | chr3:102961660-102961661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574676736 | chr3:102961670-102961671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542047248 | chr3:102961684-102961685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373378055 | chr3:102961718-102961719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540856600 | chr3:102961728-102961729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs544526230 | chr3:102961740-102961741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:102961200-102962200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |